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We have shown previously that the antiviral function of 
CD4 + T lymphocytes against murine cytomegalovirus 
(MCMV) is associated with the release of interferon-?, 
(IFN-),). We now demonstrate hat IFN-?, and tumour 
necrosis factor alpha (TNF-~<) display synergism in their 
antiviral activity. As little as 2 ng/ml of IFN-), and 
TNF-~ reduced the virus yield by about hree orders of 
magnitude. There was no effect on immediate early (IE) 
and early (E) gene expression as far as the candidate 
genes IE1, E1 and those encoding the major DNA- 
binding protein and the DNA polymerase were con- 
cemed. Late gene transcription, assayed by the can- 
didate genes encoding lycoprotein B and the MCMV 
homologue of ICP 18.5, was blocked and MCMV DNA 
replication was found to be reduced but not halted. The 
most prominent finding of the cytokine ffect, seen by 
electron microscopy, was an alteration of nucleocapsid 
formation. Altogether, the synergism is multifaceted and 
acts at more than one stage during viral morphogenesis. 
Because the cytokines clearly do not act at an early stage 
of infection we conclude that the mode of cytokine 
activity differs between alpha- and betaherpesviruses. 
Introduction 
Cytomegalovirus (CMV), a member of the herpesviridae 
family, establishes both acute and chronic infections. 
Infection threatens theimmunocompromised rather than 
the immunocompetent host. Studies on i fection of mice 
with murine CMV (MCMV), a model for human CMV 
disease, have shown that natural killer cells provide 
resistance to infection with high doses of virus (Welsh et 
al., 1991), whereas T lymphocytes are required for virus 
clearance and survival (reviewed by Koszinowski et al., 
1990). CD8 + T lymphocytes represent the major pro- 
tective principle, but cannot prevent horizontal infection 
in the absence of CD4 + T lymphocyte functions (Jonjid et 
al., 1989). In the absence of CD8 + T lymphocytes, CD4 + 
lymphocytes fully replace their function and provide 
virus clearance (Jonjid et al., 1990). The function of the 
CD4 + T cells is known to be associated with the release 
of interferon-), (IFN-y) because neutralization of endo- 
genous IFN-?, prevents CD4 + T lymphocyte function 
in vivo (Lurin et al., 1992). Therefore, IFN-~ must play a 
central role in the control of MCMV replication #7 vivo. 
IFN-y on its own has only a moderate antiviral effect 
against MCMV in vitro, and therapy with recombinant 
IFN-?~ cannot replace antiviral functions of T cells in vivo 
(Lurin et al., 1992). We therefore reasoned that the 
activity of IFN-), against CMV may be solely mediated 
by a supportive function for the antiviral activity of T 
lymphocytes. This supportive function could be associ- 
ated with the increase in the expression of IFN-y sensitive 
genes, for instance those encoding the MHC class I and 
II molecules. Increased expression of these proteins 
might result in enhanced antigen presentation. Another 
possibility, not mutually exclusive of the former, is that 
IFNp must associate with other cytokines to exhibit a 
direct antiviral effect. It has been reported that turnout 
necrosis factor (TNF) and IFN-~ in combination have 
synergistic antiviral activity against DNA viruses uch as 
adenovirus type 2 (Mayer et al., 1992; Wong & Goeddel, 
1986), herpes implex virus type 1 (HSV-1) (Feduchi et 
al., 1989) and HSV-2 (Wong & Goeddel, 1986) and 
pseudorabies virus (Schijns et al., 1991). The TNFs 0~ and 
fl (TNF-~/fl) are synthesized by monocytes and lympho- 
cytes respectively, bind to the same receptor and have 
indistinguishable biologica/ activities (Aggarwal et al., 
1985; Beutler & Cerami, 1989; Paul & Ruddle, 1988). 
We have therefore studied the effect of IFN-), and 
TNF-c~ on MCMV replication in vitro. 
Here we demonstrate that these cytokines display 
synergy in their antiviral function. We report hat IFN-y 
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interferes with MCMV replication whereas TNF-~ has 
very little effect on MCMV replication but strongly 
augments the antiviral function of IFN-),. The antiviral 
state is achieved with non-toxic oncentrations between 
1 and 5ng/ml of both cytokines and results in a 
reduction of the yield of infectious virus by more than 
three orders of magnitude. The cytokines interfere with 
MCMV maturation mainly during the late phase of the 
virus replication cycle. 
Methods 
Cells and viruses. Sucrose gradient-purified mouse embryo fibroblast 
culture-propagated MCMV (strain Smith; code VR-194; ATCC) was 
used. BALB/c secondary embryonal fibroblasts were prepared as 
described previously (Keil et al., 1985) and propagated in MEM 
(Gibco) supplemented with 5 % (v/v) fetal calf serum (Gibco), 2 mM- 
I,-glutamine, 100 Bg/ml of streptomycin and 100 units/ml of penicillin. 
Cells were infected with MCMV using the technique of centrifugal 
enhancement of infectivity at 800 g for 30 min (multiplication factor of 
20). 
Reagents and antibodies. Recombinant (r) murine IFN- 7 and 
rTNF-a were generously provided by G. R. Adolf, Bender, Vienna, 
Austria. Specific activity of rlFN-y stock (lot no. H3.RD48) was 
107 units/rag, as determined by the L cell encephalomyocarditis virus 
bioassay. Specific activity of rTNF-c~ stock was 5 × 10 r units/rag, as 
determined by a standard cytotoxicity assay on L929 cells in the 
presence of actinomycin D (ActD) (Aggarwal et al., 1985). To inhibit 
transcription and translation, ActD (5 gg/ml) and cycloheximide (CH) 
(50 gg/ml) were used, respectively. Antiserum to pp89 (1El) non- 
structural MCMV protein was produced in rabbits after immunization 
with the synthetic peptide P(34-53) (del Va le t  al., 1988); the 
monoclonal antibody (MAb) 20/234/28 (mouse IgGl) recognizes 
nuclear early protein E1 of 36K and 38K (Bfihler et al., 1990); antiserum 
against glycoprotein B (gB) was produced by rabbit immunization with 
a vaccinia virus gB recombinant (Rapp et al., 1992); MAb against 
vertebrate actin (clone C4, mouse IgG1) was obtained from Boehringer 
Mannheim, 
hnmunoprecipitation. Cells were labelled with 150gCi/ml of 
[35S]methionine (Amersham) and lysed in buffer containing 10 mM- 
Tris-HCl pH 7"5, 150 mM-NaCI, 1% NP40, 0-1% SDS, 1% sodium 
deoxycholate and 1 mM-PMSF. Immunoprecipitation, SDS-PAGE 
and fluorography were carried out as described previously (Keil et al., 
1985). In brief, samples of cell lysates equivalent to 2 x 105 cells were 
incubated with 10 lal of antiserum orwith 3 gl of ascitic fluid containing 
monoclonal ntibodies. Antigen-antibody complexes were precipitated 
with Protein-A Sepharose (Pharmacia). 
RNA analysis. Murine embryonal fibroblasts (MEF) were infected 
with MCMV at an m.o.i, of 10. Total cellular RNA was isolated 
according to the method of Chirgwin et al. (1979). Denatured RNA 
samples were size-fractionated by agarose gel electrophoresis and 
transferred to nylon membranes (GeneScreen, NEN) according to the 
instructions of the manufacturer. Membranes were prehybridized for 
3 h in 5 x SSC, 5 x Denhardt's solution (1 x solution contains 0-02% of 
each of BSA, polyvinylpyrrolidone and Ficoll 400), 1% SDS, 10% 
dextran sulphate and 250 lag/ml salmon sperm DNA at 68 °C. 
Hybridizations were carried out overnight, under the same conditions, 
with a radioactively abelled probe. DNA probes used for hybridization 
were labelled with [c~YP]dCTP (Amersham) by using a randomly 
primed DNA labelling system (Boehringer Mannheim). 
The following genomic fragments were used as probes. (i) An 821 bp 
EcoR1 fragment (map units 0-396 to 0.393) from the MCMV HindlII 
D region served as a probe for the gene encoding the major DNA- 
binding protein (MDBP) (Messerle t al., 1992). (ii) A 1734 bp PstI 
fragment (map units 0.383 to 0-376) from the MCMV HindIII D region 
served as a probe tbr the gene encoding protein ICP 18-5 (Messerle 
et al., 1992). {iii) An 850 bp XbaI/PvuI I  fragment (map units 0.3663 to 
0-370) from the MCMV H#zdIII D region served as a probe for the gB 
gene (Rapp et al., 19921). (iv) A 1190 bp HindI I I /SmaI fragment (map 
units 0.351 to 0-356) from the MCMV HindIII D region served as a 
probe specific for the MCMV DNA polymerase gene (Elliot et al., 
1991). (v) Full-length cDNA from the human fibroblast cytoplasmic fl 
actin gene was used as probe for a cellular gene (Gunnig et al., 1983). 
DNA analysis. Cells were lysed in a buffer containing 0.5 % SDS, 
0-1 M-NaCI, 001 u-Tris-HCl, 0.025 M-EDTA and 0.2 gg/ml proteinase 
K pH 8-0 for 16 h at 56 °C. Total cellular DNA was extracted by 
phenol-chloroform isoamyl alcohol treatment and digested overnight 
with HindIII. Southern blotting to a nylon membrane (GeneScreen, 
NEN) was performed after electrophoresis of DNA fragments on a 
0.6 % agarose gel. "['he membranes were prehybridized at65 °C for 3 h 
in a buffer containing 5 x SSPE, 5 x Denhardt's olution, 0.1% SDS 
and 100 gg/ml denatured sahnon sperm DNA. After hybridization 
with the radioactively labelled probes under the same conditions for 
20 h flters were washed and subjected to autoradiography. 
To analyse the DNA content of released virions, cell-free culture 
supernatants were centrifuged at 30000 g for 1 h and pelleted virions 
were then blotted onto a nylon filter (GeneScreen) by using a vacuum 
blotter (Bio-Rad). After denaturation with 0.5 M-NaOH in 1 M-NaCI 
and neutralization with 3 M-NaCI, 0-5 M-Tris-HC1 pH 7.4, the filters 
were subjected to hybridization as described above. 
For hybridization, a fragment from plasmid IE I l l  (Keil et al., 
1987), comprising the IEI and IE3 genes, was labelled with [a- 
~2P]dCTP (Amersham), using a randomly primed DNA labelling 
system (Boehringer Mannheim). 
Electron microscopy. Twenty-four and 48 h post-infection (p.i.) cells 
were trypsinized and fixed with 2.5 % glutaraldehyde in 0.1 M-sodium 
cacodylate buffer pH 7.2 for 2 h, washed and soaked in 1% osmium 
tetroxide. Specimens were dehydrated in propanol, propylene oxide 
and embedded in Epon. Ultrathin sections were stained with uranyl 
acetate and lead citrate, and examined in a Philips 301 electron 
microscope at 80 kV. 
Results 
Synergistic effect of lFN-y and TNF-o~ on MCMV 
rep l i ca t ion  
The combined  act iv i ty  o f  IFN-) ,  and  TFN-~ on  MCMV 
rep l i ca t ion  was assessed by  v i rus  p laque  number  e- 
duct ion  and  by  the quant i f i ca t ion  o f  v i rus  product ion .  
Because s imul taneous  in fec t ion  and  cytok ine  t reatment  
had  no  effect on  v i rus  rep l i ca t ion  (data  not  shown)  MEF  
were first incubated  w i th  cytok ines  for 48 h and  then  
in fected w i th  MCMV.  As  demonst ra ted  in Fig.  1 
cy tok ine  t reatment  resu l ted in s igni f icant  inh ib i t ion  o f  
MCMV rep l icat ion .  P re t reatment  o f  cells w i th  IFN-) ,  
a lone  c lear ly  reduced v i rus p laque  fo rmat ion  in a dose-  
dependent  manner ,  whereas  TNF-~ on  its own exerted a 
weak  inh ib i to ry  act iv i ty  (Fig.  1 a). In  accordance  w i th  
our  p rev ious  observat ions  (Lu6 in  et  al . ,  1992) a con-  
cent ra t ion  o f  about  5 ng /ml  o f  I FN-7  was requ i red  to 
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Fig. 1. Synergistic effect of rIFN-7 and rTNF-e on MCMV replication. 
Virus plaque formation (a) and virus yield (b) were determined in MEF 
after pretreatment with cytokines. The cells were treated for 48 h with 
recombinant cytokines, the cytokines were removed, and the cells were 
infected with MCMV (100 p.f.u./well). Number of plaques (a) and 
total virus yield (b) were determined after 4 days and 3 days, 
respectively. The results represent the mean percent reduction from 
triplicate culture (a) and the mean virus yield from four replicate 
cultures (b). Hatched areas indicate toxic concentrations of cytokines 
and dotted areas indicate concentrations of cytokines resulting in 
plaques of significantly smaller size. ( , )  TNF-treated: (A)  IFN- 
treated; (0 )  TNF/IFN-treated. 
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reduce the number of plaques by 50 %. Although high 
concentrations of a single mediator were required for 
plaque reduction, after addition of both cytokines an 
effect was seen even at physiological mediator concen- 
trations. In combination with 1 ng/ml of TNF-c~ a 100- 
fold lower concentration of IFN-~ (0"05 ng/ml) was 
sufficient o achieve 50 % plaque reduction. Thus, the 
combination of both cytokines has a synergistic effect 
which results in a significant reduction of plaque 
numbers. 
The individual cytokines were not toxic, as assessed by 
crystal violet staining, even at the highest concentrations 
used (50 ng/ml of IFN-7 and 500 ng/ml of TNF-~; data 
not shown). The combination of IFN-), and TNF-~ had 
some inhibitory effects on cell growth. The hatched areas 
in Fig. 1 (a) indicate concentrations at which such effects 
were detectable. The combination of 5 ng/ml of IFN-), 
and 5 ng/ml of TNF-c~ was not toxic for MEF after 48 h 
of treatment and resulted in an 85 % reduction of plaque 
numbers. 
The plaques formed in monolayers pretreated with 
cytokines were of a significantly smaller size (showed by 
dotted area on Fig. 1 a). This finding was suggestive of an 
effect upon virus production. To test this, virus yield was 
determined 72 h after infection (Fig. 1 b). Pretreatment 
with IFN- 7 resulted in a nearly 1.5 log10 reduction in 
virus yield, whereas pretreatment with TNF-~ did not 
have a significant effect. As expected, the combination of 
both cytokines acted synergistically and reduced virus 
yield by almost three orders of magnitude. This is 
exemplified by the fact that 0-1 ng/ml of IFN-), in 
combination with 0.1 ng/ml TNF-e sufficed to achieve 
the effect of 10 ng/ml of the IFN-;, in absence of TNF- 
e. In conclusion, the combination of IFN-;, with TNF-e 
results in a moderate reduction of plaque numbers and a 
strong reduction f virus yield. 
These results uggest a physiological function of these 
cytokines in the reduction of virus production at the level 
of the individual cell and of the subsequent transmission 
of infection to neighbouring cells. Notably, infection of 
cultures with a low m.o.i. (0-001), i.e. the infection of 
only few cells at the start of the experiment, resulted in 
a more than 2 log10 lower virus yield in cells treated with 
IFN-), alone and an almost 4 log10 lower virus yield when 
both cytokines were applied. In contrast, infection with 
a higher m.o.i. (1), i.e. the simultaneous infection of the 
majority of cells, reflects the antiviral activity of cytokines 
at the individual cell level. In this case virus yield was 
reduced only 10-fold after IFN- 7 treatment and about 
100-fold after combined IFN- 7 and TNF-e treatment 
(data not shown). Therefore, the individual virus dose 
and the dynamics of tissue infection eed to be taken into 
account for full evaluation of the antiviral activity of 
these cytokines. 
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Fig. 2. Selective effect of cytokines on the synthesis of MCMV proteins. 
After incubation with rIFN-7 (5 ng/ml) or rIFN-7 and TNF-c~ (both at 
concentrations of 5 ng/ml) for 30 h cells were infected with MCMV 
(m.o.i. 10), To study the synthesis of IE proteins, the infection was 
carried out in the presence of CH for 3 h which was replaced by ActD 
and [35Slmethionine for an additional 4 h. Early proteins were labelled 
with [3SSJmethionine from 3 to 7 h. Late proteins were labelled from 18 
to 24 h p.i. Cell lysates were immunoprecipitated with rabbit antiserum 
to peptide Pt34-53) ofpp89 (IEI), MAb 20/234/28 to E1 protein, and 
rabbit antiserum to gB. The MAb C4 to actin served as a control for 
a cellular gene. 
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Fig. 3. Cytokine effect on MCMV transcripts. RNA was isolated from 
mock-infected cells (lane 1), MCMV-infected cells (m.o,i. 10) without 
cytokine preincubation (lane 21), or cells incubated for 30 h with 
5 ng/ml of TNF (lane 3), IFN (lane 4) or TNF and IFN (lane 5) prior 
to MCMV infection. Total cellular RNA was isolated 24 h p.i., 
separated by agarose gel electrophoresis and hybridized with the 
specific probes, 
hthibition of late phase protein synthesis 
The synergistic effect of IFN-? and TNF affects a step 
before or at the transcription of immediate arly (IE) 
genes of HSV-1 (Feduchi et al., 1989). To elucidate at 
which stage during MCMV replication the cytokines 
exert their inhibitory activity, the synthesis of viral 
proteins representative of the IE, early (E) and late 
phases of the MCMV replication cycle was studied. Cells 
were labelled with [35S]methionine and lysates were 
immunoprecipitated with antibodies specific for the 
candidate proteins. Immunoprecipitation with pp89 
(IE1)-specific antiserum showed some inhibitory cyto- 
kine effect on the synthesis rate of this protein during the 
IE phase, whereas during the E phase cytokine treatment 
enhanced the synthesis of pp89 and during the late 
phase synthesis was prevented (Fig. 2). The differential 
abundance of pp76, a degradation product of pp89 (Keil 
et al., 1985), was not related to a cytokine effect as it is 
also observed in samples not treated with cytokines. The 
synthesis of the E phase products of the E1 gene was, if 
affected at all, enhanced uring the early phase. Similar 
results were observed for both the 53K and the 69K early 
proteins which belong to a second set of early genes 
(Btihler et al., 1990) (data not shown). The finding that 
the synthesis of the candidate arly proteins was not 
reduced by cytokine treatment indicated that the ob- 
served minor inhibitory effect on 1El synthesis during 
the IE phase was functionally irrelevant. At late times of 
MCMV infection the combination of cytokines reduced 
IE1 protein synthesis. The synthesis of gB, a late phase 
protein, was significantly inhibited following pretreat- 
ment with IFN-7 and almost completely prevented after 
application of both cytokines. These results suggest that 
the mode of antiviral activity of these cytokines differs 
between herpesviruses and that one important mani- 
festation of the cytokine-induced block in MCMV 
replication is a selective reduction of the synthesis of viral 
proteins during the late phase. Note that the effect of 
cytokines on viral protein synthesis was not paralleled by 
a similar effect on cellular protein synthesis ince no 
difference in the synthesis of actin was observed. In 
addition, as was expected, the synthesis of IFN-7- 
responsive proteins (eg. MHC class I gene-encoded 
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Fig. 4. Analysis of DNA from cytokine-treated cells. Total cellular 
DNA was isolated 24 h p.i. from cells mock-infected (lane 1), MCMV- 
infected (m.o.i. 10) without cytokine preincubation (lane 2). or cells 
incubated for 30 h with 5 ng/ml ofTNF (lane 3), IFN (lane 4) or TNF 
and IFN (lane 5) prior to MCMV infection. After digestion with 
HindIII Southern blot (a)and dot-blot (b) analysis were performed 
using a HindIII K/L-specific probe. 
proteins) was increased by 10- to lO0-fold (data not 
shown). 
Inhibition of late phase transcription 
Reduced late phase protein synthesis could be due to the 
inhibition of transcription or to an effect on transcript 
stability. Therefore, Northern blot analysis was per- 
formed at different imes after MCMV infection. Tran- 
scription of MCMV genes during the IE (IE1) and E (E 1) 
phases was not affected (data not shown). In the late 
phase (24 h p.i.), a selective ffect was seen in that the 
accumulation of certain transcripts was inhibited. The 
accumulation of MDBP gene and polymerase gene 
transcripts appeared to be normal or even stimulated in 
cells pretreated with cytokines (Fig. 3). Both the MDBP 
and polymerase genes represent E genes with maximal 
transcription at the end of the E phase and at the 
beginning of the late phase (Messerle t al., 1992; Elliot 
et al., 1991). In contrast, transcripts of certain late genes 
(gB and ICP 18.5) were found to be significantly reduced 
following IFN-y treatment and particularly following 
combined IFN-7/TNF-~ treatment. Therefore, pre- 
incubation of cells with these cytokines induces an 
antiviral state which affects late phase transcription, late 
transcript stability, or both. 
Effect of lFN-~ and~or TNF-o~ on viral DNA synthesis 
Inhibition of viral DNA synthesis by phosphonoacetic 
acid or Gancyclovir prevents the expression of late phase 
genes (Keil et al., 1984). Thus, reduced expression of late 
genes could be a consequence of inhibited viral DNA 
synthesis caused by cytokine treatment. To quantify the 
cytokine ffect on MCMV DNA synthesis, Southern blot 
analysis was performed. Total DNA was extracted from 
infected cells and digested with HindIII. Ethidium 
bromide staining after separation on an agarose gel 
showed the same fragment pattern in infected normal 
cells and in cytokine-treated cells, suggesting that 
elongation of newly synthesized DNA occurred normally 
(data not shown). Southern blot analysis with a probe 
specific for the HindIII K and L fragments upported 
this observation and demonstrated quantitative effects of 
cytokine pretreatment on viral DNA synthesis (Fig. 4a). 
Titration of digested DNA and subsequent dot-blot 
analysis using the same probe revealed that viral DNA 
synthesis was reduced but not completely prevented. The 
reduction was about fivefold in IFN-y-treated cells and 
about 10-fold in IFN-),/TNF-c~-treated cells (Fig. 4b). 
Clearly, a reduction in infectious progeny number by 
three orders of magnitude can not be explained by this 
limited effect upon viral DNA synthesis. 
Assembly of nucleocapsids and maturation of virions in 
cytokine-treated cells 
Reduced transcription and translation of MCMV late 
genes hould have direct consequences onthe maturation 
of MCMV virions. Therefore, MCMV morphogenesis 
was analysed by electron microscopy 24 and 48 h after 
infection. In the absence of cytokine treatment nucleo- 
capsids, predominantly those with an electron-lucent 
core, arise in the nuclei of MCMV-infected cells together 
with morphological changes in nuclear structures 
(Weiland et al., 1986) (Fig. 5a and c). Formation of 
CMV inclusion bodies and nuclear dense bodies precedes 
the appearance ofnucleocapsids (Fig. 5 a). The cytoplasm 
contains typical cytoplasmid multicapsids as well as 
monocapsids enveloped by cellular vacuoles (Fig. 5 a). At 
24 h p.i. the cells were heterogeneous with respect o the 
phase of virus replication since 24.4 % of cells did not 
contain capsids, 29.5 % of cells contained only nuclear 
capsids and 46.1% of cells contained both nuclear and 
cytoplasmic nucleocapsids. At 48 h p.i., however, nucleo- 
capsids were found in both the nuclei and cytoplasm 
of almost all cells (Table 1). 
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Fig. 5. Cytokine effect on MCMV morphogenesis. Cells were treated as outlined in Table 1. Electron microscopy was carried out 
24 h p.i. (a, b) and 48 h p.i. (c, d). (a) Distribution of nucleocapsids and MCMV-induced morphological changes. (b) Incompletely 
formed nuclear inclusion body and the absence ofnucleocapsids n IFN-7/TNF-c~-treated c lls 24 h p.i. (c) Predominance of electron- 
lucent-core capsids in the nucleus 48h p.i. (d) Appearance ofnucleocapsids n IFN-),/TNF-~-treated cells 48 h p.i. IB, Inclusion body. 
NDB, Nuclear dense body. Bar markers represent 2 gm (a and b)and 200 nm (c and d). 
Both IFN-?, and IFN-~,/TNF-~ pretreatment of cells 
altered the morphogenesis of MCMV. At 24 h p.i. only a 
few cells with nucleocapsids could be detected (Table 1). 
Many cells contained incompletely formed inclusion 
bodies which is suggestive of an inhibition of mor- 
phogenesis prior to the appearance of nucleocapsids 
(Fig. 5 b). At 48 h p.i. the majority of IFN-~-treated cells 
contained nucleocapsids both in the nucleus and cyto- 
plasm, while in IFN-),/TNF-0~-treated cells 58.1% of 
cells lacked cytoplasmic nucleocapsids (Table 1). In- 
spection of the cells at a higher magnification revealed 
not only a delayed but also an altered morphogenesis. In 
the nucleus of IFN-7/TNF-c~-treated cells capsids with 
electron-lucent cores predominated. The inner shell in 
most of these capsids was interrupted and contained 
discrete accumulations of electron-dense material (Fig. 
5d). This type of nucleocapsid appears to represent a
transient stage during MCMV morphogenesis since these 
forms represent only a minority in normal cells (Fig. 5 c). 
The numeric increase of these incompletely formed 
electron-lucent-core nucleocapsids was the prominent 
characteristic of IFN-7/TNF-e-treated cells. With re- 
spect to cytoplasmic nucleocapsids only quantitative 
differences and no alterations in morphology were seen. 
Accumulation of diffusely arranged amorphous material 
representing nuclear inclusion bodies was typical for 
cytokine-treated cells that did not, either at 24 or 
48 h p.i., contain nucleocapsids (Fig. 5b). Therefore, it 
seems that morphogenesis of MCMV is altered at 
multiple stages after IFN-), and IFN-7/TNF-~ treatment. 
Table 1. Cytokine effect on formation and distribution 
of nucleocapsids 
Formation and distribution of 
nucleocapsidst (%) 
Nuclear 
Time p.i. No Only and 
(h) Treatment* capsids nuclear cytoplasmic 
24 
48 
0 24.4 29-5 46.1 
1FN-y 97.6 1.6 0.8 
TNF-c~ 37.5 9-2 53.3 
1FN-7/TNF-~ 99.0 0.5 05 
0 l- 1 6.9 92-0 
1FN-7 27.9 2-7 69.4 
TNF-c~ 5.8 3.6 89-6 
1FN-7/TNF-c~ 14-2 43.9 41.9 
* To MEF rIFN- 7 (5 ng/ml) or rTNF-c~ (5 ng/ml) or both cytokines 
was added. Infection with MCMV at an m.o.i, of 10 was carried out 
30 h later. Cells were subjected to electron microscopy 24 and 48 h p.i. 
t Two-hundred individual cells were analysed by electron micro- 
scopy. 
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Fig, 6. Effect of cytokine treatment on virion infectivity. Cells were 
mock-infected (lane 1), MCMV-infected (m.o.i. 1) without cytokine 
preincubation (lane 2), or incubated for 30 h with 5 ng/ml of TNF 
(lane 3), IFN (lane 4) or TNF and IFN (lane 5) prior to MCMV 
infection (m.o.i. 1). Forty-eight hours after infection the number of 
infectious virus units was determined by a plaque assay (a) and the total 
viral DNA in supernatants was estimated by blotting of an aliquot of 
pelleted virions and subsequent hybridization with a HindIII K/L- 
specific probe (b). 
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The maturation ofnuclear inclusion bodies, the assembly 
of nucleocapsids and the egress of mature nucleocapsids 
from the nucleus appear to be major points of cytokine 
action during MCMV morphogenesis. Treatment of cells 
with TNF-~ alone did not detectably affect he assembly 
of MCMV virions; this was expected from the minor 
effect on virus productivity and the biochemical nalysis. 
Infectivity of virions released from cytokine-treated cells 
A reduced synthesis of viral DNA and the decrease in 
late gene expression should result in the release of a 
smaller number of MCMV particles. In addition, many 
of these particles should have a reduced infectivity or 
lack this property altogether owing to their defects in 
morphogenesis and lack ofgB. To test his, the cells were 
infected at an m.o.i, of 1 and virus yields in supernatants 
were determined. At this m.o.i., pretreatment of cells 
with IFN-y reduced the release of infectious particles 
eight- to 10-fold, but the combined cytokine tr atment 
reduced infectious virus yield by two orders of magnitude 
(Fig. 6a). Blotting of virions from supernatant onto the
nylon filter and subsequent hybridization with an 
MCMV DNA-specific probe showed a fourfold re- 
duction in DNA content after IFN- V treatment and after 
combined cytokine treatment the DNA content was 
reduced by a factor of eight (Fig. 6b). If the DNA 
content is taken as an estimate for the genome number 
we must conclude that 90% of these genomes are 
contained in non-infectious particles. Therefore, both a 
reduced release of virions and a reduced infectivity of 
these virions are the consequences of the synergistic 
action of IFN- 7 and TNF. 
Discussion 
The cytokines IFN-7 and TNF exhibit synergism in the 
induction of resistance against certain RNA and DNA 
viruses. Among DNA viruses~ adenovirus (Wong et al., 
1986; Mayer et al., 1992), African swine fever virus 
(Esparza et al., 1988), and the alphaherpesviruses HSV 
(Wong et al., 1986; Feduchi et al., 1989) and pseudo- 
rabies virus (Schijns et al., 1991) have been found to be 
susceptible to this combination of cytokines. Here we 
report hat the replication of MCMV, a betaherpesvirus, 
is also susceptible to their synergistic action. Thus~ in 
order to explain the antiviral effect of CD8 + and CD4 + T 
lymphocytes against CMV in vivo, not only the direct 
cytolytic activity of these effector cells, but also, and 
probably much more importantly, the effect of cytokines 
released by these cells have to be considered. 
Strong effects are seen even at low cytokine concen- 
trations which may be reached locally during the 
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initiation of an immune response in vivo. The general 
notion that the induction of an antiviral state requires 
exposure of cells to the cytokine prior to infection also 
applies in this case. Because of its slow replication cycle 
CMV is probably particularly vulnerable to this type of 
immune control. Recognition of viral proteins expressed 
during the IE or E phase of the replication cycle by 
activated T lymphocytes could perhaps trigger acytokine 
release sufficient forthe induction of an antiviral state in 
cells neighbouring the infected cell even before infectious 
progeny is released. Evidence in support of this hy- 
pothesis is our finding that neutralization of IFN-~, 
completely cancels the antiviral effect of CD4 + T 
lymphocytes in the salivary gland and prevents virus 
clearance (Lu6in et al., 1992). 
Although the combined cytokines TNF and IFN-), act 
on both alpha- and betaherpesviruses, surprisingly the 
specific mode of action is different. In their study on 
HSV-1 replication Feduchi et al. (1989) placed the 
synergistic action at a very early step, after virus entry 
but before or at the transcription ofIE genes, because the 
expression ot only of early thymidine kinase and late 
(),0) genes but also of IE genes (c¢22) was inhibited. 
Earlier data on the inhibitory function of interferons in 
the absence of TNF on HSV-1 and -2 also indicated a
suppression of IE and E gene expression exemplified by 
the genes for ICP4 and DNA polymerase (Domke-Opitz 
et al., 1986). 
In our study on the targets of the cytokine action we 
tested a selection of individual genes from the three 
temporal phases of the MCMV replication cycle that 
have been defined. The analysis of these candidate genes 
allowed us to reach the firm conclusion that the mode of 
action in MCMV must differ from that described for 
HSV. We would place the effect mainly in the late phase 
and in the transitional step between the E and late 
phases. We reach this conclusion for the following 
reasons: a significant effect at IE and E times is unlikely 
because the expression of the IE1 gene product pp89 was 
not affected; moreover there was no inhibition of the E 1 
gene product and there was no effect on transcription of
the E genes encoding the DNA polymerase and MDBP, 
two of the seven E genes involved in the control of 
herpesviral DNA synthesis (Wu et al., 1988). Yet, 
MCMV DNA replication was found to be reduced by a 
factor of five- to 10-fold. Host cell mechanisms are 
required for the transport of the HSV-1 MDBP to the 
nucleus and to replication compartments, and com- 
ponents of the cellular DNA replication apparatus 
contribute to the efficiency of HSV DNA synthesis (De 
Bruyn Kops & Knipe, 1988). Additional targets for the 
cytokine action, therefore, may be the host cell com- 
ponents that are involved in viral DNA replication. An 
observation that the cytokines inhibit cellular DNA 
synthesis (P. Lu6in & U. H. Koszinowski, unpublished 
data) and the notion that MCMV requires events 
associated with the host S phase for initiation of DNA 
replication (Muller & Hudson, 1977) support this 
hypothesis. Finally, by concentrating solely on a few 
candidate viral genes we may have missed astep at which 
the cytokine action could have interfered with E gene 
function. Altogether it is clear, however, that a reduction 
of DNA replication by one order of magnitude at 
maximum cannot account for a 1000-fold reduction in 
the yield of infectious virus. 
Of true late genes only one candidate, the MCMV gB 
gene (Rapp et al., 1992), was amenable to analysis. This 
gene encodes a glycoprotein which is conserved in all 
herpesviruses that have been characterized at the 
molecular level. The expression of this glycoprotein is
essential lbr herpesvirus infectivity (Cai et al., 1988). 
Even if we make the conservative assumption that this 
effect is the only alteration in the expression of late 
proteins, the drastic reduction in gB expression under 
combined IFN-)~/TNF-v. treatment would by itself 
explain the biological findings. We assume that the 
combined cytokine effect acts essentially at the level of 
transcription of gB because the reduction was not 
accompanied by a detectable alteration of the post- 
translational processing of the protein. Although the 
significant reduction of gB synthesis could explain the 
experimental findings the situation is probably more 
complex. The difference in viral morphogenesis we 
observed is suggestive of an effect on additional genes. 
Two findings are worth recollecting. First, although 
there was no difference observed in the sequential steps 
of the replication cycle, nucleocapsid formation in the 
nucleus and particle export into the cytoplasm for 
further maturation were reduced and very slow in 
cytokine-treated cells. This maturation defect was not 
merely adelay because the analysis after 72 and 96 h still 
showed the same reduction in virus titres (data not 
shown). Secondly, the alteration of nucleocapsid form- 
ation has to be considered. In normal cells the majority 
of electron-lucent nucleocapsids take the form of double 
shells and nucleocapsids with an incomplete inner shell 
represent a minority. Remarkably, the latter form 
predominates in cytokine-treated cells. The enzymatic 
degradation of the inner shell of the capsid probably 
represents a step prior to the take-up of the electron- 
dense core material (Weiland et al., 1986). If this order of 
events is correct, the function responsible for this inner 
shell degradation might represent a target for the 
cytokine ffect, and this results in the accumulation of
these otherwise transient forms. Insufficient synthesis of 
late proteins that are involved in nucleocapsid assembly, 
as exemplified by the product of the ICP 18.5 gene 
homologue (Addison et al., 1990), also presumably 
contributes to the different morphogenesis of MCMV in 
cytokine-treated cells. In addition, reduced DNA syn- 
thesis and inhibited expression of late glycoproteins 
results in release of reduced numbers of virions, the 
majority of which are non-infectious. Taken together, 
these multiple targets or multiple consequences of the 
antiviral cytokine action on the MCMV replication cycle 
explain the synergistic effect. 
In conclusion, our studies in a model system for 
human CMV disease have pointed to an important and 
synergistic role of cytokines in the control of virus 
clearance. In theory these two cytokines in combination 
could represent an antiviral preparation suitable for 
medical use. Unfortunately, for various reasons systemic 
application is probably not the method of choice. These 
cytokines act locally and their potential activity can be 
effectively demonstrated when they are produced at the 
site of virus replication, for instance by recombining the 
respective cytokine gene into the virus under study 
(Kohonen-Corish et al., 1990; Sambhi et al., 1991). 
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